Page last updated: 2024-12-06

thiazolidine-2-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Thiazolidine-2-carboxylic acid (T2CA) is a heterocyclic compound that has been extensively studied for its pharmacological properties. It is a known inhibitor of aldose reductase, an enzyme involved in the development of diabetic complications. T2CA is also a potent anti-inflammatory agent and has been shown to reduce oxidative stress and protect cells from damage. The synthesis of T2CA involves the reaction of cysteine with a carbonyl compound, typically an aldehyde or ketone. The importance of T2CA lies in its potential therapeutic applications in the treatment of diabetes, inflammation, and other diseases. Researchers continue to study T2CA to explore its mechanisms of action and optimize its therapeutic efficacy.'

thiazolidine-2-carboxylic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

thiazolidine-2-carboxylic acid : A thiazolidinemonocarboxylic acid that is 1,3-thiazolidine substituted by a carboxy group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID42486
CHEMBL ID3245365
CHEBI ID177353
SCHEMBL ID23170
MeSH IDM0077058

Synonyms (40)

Synonym
2-thiazolidinecarboxylic acid
16310-13-7
CHEBI:177353
thiazolidine-2-carboxylic acid, 97%
beta-thiaproline
ulszvnjbvjweje-uhfffaoysa-
inchi=1/c4h7no2s/c6-4(7)3-5-1-2-8-3/h3,5h,1-2h2,(h,6,7)
1,3-thiazolidine-2-carboxylic acid
tetrahydrothiazole-2-carboxylic acid
T1324
65126-70-7
thiazolidine-2-carboxylic acid
AKOS004903172
FT-0613435
FT-0613434
FT-0613443
AM20100589
1,3-thiazolane-2-carboxylic acid
CHEMBL3245365
SCHEMBL23170
MS-1162
thiazolidine carboxylic acid
(+/-)-thiazolidine-2-carboxylic acid
STL419946
W-205917
thiazolidine-2-carboxylicacid
BBL034715
DS-1218
1,3-thiazolidine-2-carboxylic acid #
2-triazolidinecarboxylic acid
AC-27435
mfcd00068005
F10465
CS-0204253
DTXSID30936787
rac-2-thiazolidinecarboxylic acid
SB47820
EN300-88389
2-thiazolidinecarboxylic acid, (a+/-)-
Z1203162153
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
thiazolidinemonocarboxylic acidA thiazolidine or thiazolidine derivative carrying a single carboxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1133030Inhibition of L-type amino acid transporter-mediated [3H]-L-histidine uptake in mouse S37 cells assessed as residual activity at 10 mM after 2 mins by liquid scintillation counting analysis relative to control1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthetic sulfur-containing amino acids. Inhibition of transport systems in S37 ascites tumor cells.
AID1133032Inhibition of A-type amino acid transporter-mediated [3H]-L-histidine uptake in mouse S37 cells assessed as residual activity at 10 mM after 2 mins by liquid scintillation counting analysis relative to control1978Journal of medicinal chemistry, Oct, Volume: 21, Issue:10
Synthetic sulfur-containing amino acids. Inhibition of transport systems in S37 ascites tumor cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (45.45)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's3 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.63 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]